Ivax (now owned by Teva Pharmaceuticals) have received FDA approval to market their generic version of AstraZeneca’s Pulmicort Respules in 0.25mg/ml and 0.5mg/ml strengths. More details here.
Ivax (now owned by Teva Pharmaceuticals) have received FDA approval to market their generic version of AstraZeneca’s Pulmicort Respules in 0.25mg/ml and 0.5mg/ml strengths. More details here.
